FDA (Drugs) recall action 83074
The FDA (Drugs) publishes a recall like this one as 86 separate product records. They share a firm, a date and a cause; this page is all of them in one place, so the scale of the action is visible rather than spread across 86 pages.
Lack of Assurance of Sterility
Crystallization
The agency’s own wording, quoted from the enforcement report.
RXQ Compounding LLC is recalling Edetate Disodium 150mg/mL PFV vials because the product lacks assurance of sterility.
RXQ Compounding LLC is recalling Procaine HCL 8% Injectable due to a lack of assurance of sterility. The recall covers all lots within expiry distributed nationwide.
RXQ Compounding LLC is recalling Hydrogen Peroxide 3% Injectable PFV because the product lacks assurance of sterility. The recall covers all lots within expiry distributed nationwide.
RXQ Compounding LLC is recalling Buffered Lidocaine HCL 1% Injection Solution due to a lack of assurance of sterility.
RXQ Compounding LLC is recalling diazePAM 5 MG/ML Injection Solution because the product lacks assurance of sterility.
RXQ Compounding LLC is recalling Calcium Glucunate 5% Injection Solution because the FDA determined there is a lack of assurance of sterility.
RXQ Compounding LLC is recalling Prednisolone 1% and Moxifloxacin 0.5% ophthalmic solution due to a lack of assurance of sterility.
RXQ Compounding LLC is recalling Ketamine 50 mg/mL injection solution because the product lacks assurance of sterility.
RXQ Compounding LLC is recalling Magnesium Chloride Hexahydrate 20% Injection Solution because the product lacks assurance of sterility.
RXQ Compounding LLC is voluntarily recalling Ascorbic Acid 500 MG/ML Injection due to crystallization. The recall covers all lots within expiry distributed nationwide.
RXQ Compounding LLC is recalling PHO-TID-CHOL 50MG/DEOXYCHOLIC 42 MG/ML Injection due to a lack of assurance of sterility.